S&P 500
(0.65%) 5 160.99 points
Dow Jones
(0.26%) 38 778 points
Nasdaq
(0.71%) 16 271 points
Oil
(0.20%) $78.27
Gas
(4.06%) $2.23
Gold
(1.06%) $2 333.10
Silver
(3.34%) $27.58
Platinum
(-0.09%) $964.45
USD/EUR
(-0.08%) $0.928
USD/NOK
(-0.45%) $10.83
USD/GBP
(-0.16%) $0.796
USD/RUB
(-0.12%) $91.34

实时更新: Cardax, Inc. [CDXI]

交易所: PNK 工业: Biotechnology
最后更新时间27 Dec 2023 @ 22:38

0.00% $ 0.0000010

Live Chart Being Loaded With Signals

Commentary (27 Dec 2023 @ 22:38):

Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress...

Stats
今日成交量 1.00
平均成交量 0.00
市值 4.00
EPS $-1.740 ( 2021-05-14 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2014-02-24 Paulson Capital (delaware) Corp. Buy 500 000 Common Stock
2014-02-24 Paulson Cardax Investments 1 Llc Buy 500 000 Common Stock
2014-02-07 Paulson Capital (delaware) Corp. Buy 1 068 477 Warrants (right to buy)
2014-02-07 Paulson Cardax Investments 1 Llc Buy 1 068 477 Warrants (right to buy)
2014-02-07 Paulson Capital (delaware) Corp. Buy 0 Common Stock
INSIDER POWER
0.00
Last 4 transactions
Buy: 3 136 954 | Sell: 0

音量 相关性

長: -0.01 (neutral)
短: 0.00 (neutral)
Signal:(99.872) Neutral

Cardax, Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Cardax, Inc. 相关性 - 货币/商品

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.18
( neutral )
The country flag 0.00
( neutral )

Cardax, Inc. 财务报表

Annual 2022
营收: $0
毛利润: $0 (0.00 %)
EPS: $0
FY 2022
营收: $0
毛利润: $0 (0.00 %)
EPS: $0
FY 2020
营收: $538 946
毛利润: $342 816 (63.61 %)
EPS: $-6.79
FY 2019
营收: $710 949
毛利润: $365 556 (51.42 %)
EPS: $-7.49

Financial Reports:

No articles found.

Cardax, Inc.

Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia; and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax, Inc. is based in Honolulu, Hawaii.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。